These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1803250)

  • 1. Cholesterol embolism after intravenous anisoylated plasminogen streptokinase activator complex (APSAC).
    Beutler JJ; Sulzer MA; van Stralen R
    Neth J Med; 1991 Dec; 39(5-6):373-4. PubMed ID: 1803250
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypersensitivity vasculitis after thrombolytic therapy with APSAC (anisoylated plasminogen streptokinase activator complex). Presentation of a clinical case and review of the literature].
    Gianni R; Benucci M; Santoro E; Nenci G; Baruffi MC; Cappelletti C
    Ann Ital Med Int; 1994; 9(2):105-6. PubMed ID: 7917762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction.
    Vogt P; Monnier P; Schaller MD; Goy JJ; Beuret P; Essinger A; Bachmann F; Hauert J; Perret C; Sigwart U
    Am J Cardiol; 1993 Feb; 71(4):274-80. PubMed ID: 8427167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug eruptions and isotypic antibody responses to streptokinase after infusions of anisoylated plasminogen-streptokinase complex (APSAC, anistreplase).
    Dykewicz MS; McMorrow NK; Davison R; Fintel DJ; Zull CC; Rutledge JL
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):1020-8. PubMed ID: 7751498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of anistreplase on coronary patency in acute myocardial infarction].
    Pacouret G; Charbonnier B
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():25-9. PubMed ID: 2108643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rash after treatment with anistreplase.
    Burrows N; Jones RR
    Br Heart J; 1990 Oct; 64(4):289-90. PubMed ID: 2223309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiographic assessment of patency and reocclusion: preliminary results of the Dutch APSAC Reocclusion Multicenter Study (ARMS).
    Visser RF
    Clin Cardiol; 1990 Mar; Suppl 5():V45-7; discussion V67-72. PubMed ID: 2182241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolysis in acute myocardial infarct: prerequisites, current experiences and remaining problems].
    Rapold HJ
    Schweiz Med Wochenschr; 1986 Aug; 116(33):1074-87. PubMed ID: 3094141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symposium on anisoylated plasminogen streptokinase activator complex (APSAC). Proceedings of an international symposium. Guernsey, 5-6 November 1986.
    Drugs; 1987; 33 Suppl 3():1-316. PubMed ID: 3315573
    [No Abstract]   [Full Text] [Related]  

  • 12. [Syndrome of multiple cholesterol embolism after parenteral streptokinase therapy of acute myocardial infarct: description of an autopsy case].
    Matturri L; Varesi C; Rossi L
    Cardiologia; 1991 Jan; 36(1):59-61. PubMed ID: 1878901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholesterol crystal embolization after intravenous thrombolysis by anistreplase for suspected myocardial infarction].
    Coppere B; Granade G; Girard-Madoux MH; Claudel JP; Kruszynski G; Porte J; Gayral M; Ninet J
    Presse Med; 1992 Dec; 21(42):2061. PubMed ID: 1294983
    [No Abstract]   [Full Text] [Related]  

  • 14. Oesophageal dissection after thrombolytic treatment for myocardial infarction.
    Jishi F; Sissons CE; Silverstone EJ; Coakley JF; Fraser F
    Thorax; 1992 Oct; 47(10):835-6. PubMed ID: 1481188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the pharmacokinetic properties of streptokinase and anistreplase in acute myocardial infarction.
    Gemmill JD; Hogg KJ; Burns JM; Rae AP; Dunn FG; Fears R; Ferres H; Standring R; Greenwood H; Pierce D
    Br J Clin Pharmacol; 1991 Feb; 31(2):143-7. PubMed ID: 2049230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculitis occurring after intravenous anistreplase.
    Burrows N; Jones RR
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):508. PubMed ID: 1564164
    [No Abstract]   [Full Text] [Related]  

  • 17. Adult respiratory distress syndrome following thrombolytic therapy with APSAC for acute myocardial infarction.
    Le SP; Chatterjee K; Wolfe CL
    Am Heart J; 1992 May; 123(5):1368-9. PubMed ID: 1575153
    [No Abstract]   [Full Text] [Related]  

  • 18. Anistreplase for acute M.I.
    Blake GJ
    Nursing; 1990 Oct; 20(10):113. PubMed ID: 2216077
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholesterol embolization syndrome after intravenous tissue plasminogen activator for acute myocardial infarction.
    Arora RR; Magun AM; Grossman M; Katz J
    Am Heart J; 1993 Jul; 126(1):225-8. PubMed ID: 8322670
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatitis following anistreplase-induced fibrinolysis in the acute phase of myocardial infarction].
    Dubettier S; Vial T; Falque B; Finet G; Lagable M; Milon H; Evreux JC
    Presse Med; 1991 Mar; 20(9):427-8. PubMed ID: 1826780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.